Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × COVID-19 × BNT162 Vaccine × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Lymphoma 1 COVID-19 1

Interventions

BNT162 Vaccine 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05075538 2024-01-17

I-SPARC

Jules Bordet Institute

Phase 4 Terminated

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡